Biogen Inc. (Nasdaq: BIIB) announced the completion of its acquisition of RayThera Inc., a privately held biotechnology company focused on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE